A salmonella genomic island, designated SGI11, was found in 18 of 26 multidrug-resistant Salmonella enterica serovar Typhi isolates from Bangladesh. SGI11 was an IS1 composite transposon and carried 7 resistance genes that conferred resistance to 5 first-line antimicrobials. Eleven of the 18 SGI11-carrying S. Typhi isolates had developed resistance to high levels of ciprofloxacin.
A salmonella genomic island, designated SGI11, was found in 18 of 26 multidrug-resistant Salmonella enterica serovar Typhi isolates from Bangladesh. SGI11 was an IS1 composite transposon and carried 7 resistance genes that conferred resistance to 5 first-line antimicrobials. Eleven of the 18 SGI11-carrying S. Typhi isolates had developed resistance to high levels of ciprofloxacin.
S
almonella enterica subspecies enterica serovar Typhi is the etiological agent of typhoid fever, a disease that is transmitted primarily through the ingestion of contaminated food and water and that remains a major cause of morbidity in south-central Asia and southeast Asia (1) . In more-developed countries, typhoid cases are predominantly seen with returning travelers or immigrant workers from areas of endemicity (2) (3) (4) . Ampicillin (A), chloramphenicol (C), and cotrimoxazole are the first-line drugs of choice for the treatment of typhoid fever, but the intensive use of the drugs has led to the emergence and global spread of multidrug-resistant (MDR) S. Typhi strains (5) . MDR in S. Typhi is almost exclusively conferred by a suite of resistance genes carried by the IncHI1 plasmids (6) . With the introduction of fluoroquinolones, such as ciprofloxacin (Cp), for the treatment of typhoid fever, S. Typhi with elevated fluoroquinolone MICs has become prevalent (3, 7, 8) .
In a previous study, we characterized 38 S. Typhi isolates collected in Bangladesh in 2007 and revealed that 68% of the isolates were MDR, 82% were resistant to nalidixic acid (Na), and 39% were resistant to ciprofloxacin (Cp) (9) . The 26 MDR isolates were resistant to 5 to 7 antimicrobials (ampicillin, chloramphenicol, ciprofloxacin, nalidixic acid, streptomycin [S], sulfamethoxazole [Su] , tetracycline [T] , and trimethoprim [Tm] ) and were grouped into 7 resistance patterns, A2 (11 isolates resistant to ACCpNaSSuTm), A3 (1 resistant to ACpNaSSuT), A4 (3 resistant to ACpNaSuT), A5 (2 resistant to ACNaSSuTTm), A6 (6 resistant to ACNaSSuTm), A9 (2 resistant to ACSSuTTm), and A11 (1 resistant to ACSSuTm). Of the isolates, 4 (with A5 and A9 patterns) harbored IncHI1 plasmids, 10 (A3, A4, and A6) harbored large non-IncHI1 plasmids, and 12 (A2 and A11) did not harbor any plasmid. Hybridization analysis suggested that the MDR genes were carried by IncHI plasmids in the 4 isolates with A5 and A9 patterns and by non-IncHI1 plasmids in the 4 isolates with A3 and A4 patterns but resided in the chromosome of 18 MDR isolates with A2, A6, and A11 patterns. Genotyping analysis indicated that all but 1 of the 26 MDR isolates were closely related and belonged to the dominant H58 clone in Asia and Africa (10) .
To investigate the chromosome-mediated MDR in S. Typhi, we performed whole-genome sequencing of strain Bd1380, which had the A11 resistance pattern, and strain Bd1980, which had the A2 pattern, using an Illumina Hiseq 2000 (Illumina Inc.) sequencing platform. The reads were subjected to de novo assembly using the Velvet assembler (version 1.2.1) (11), and 277 and 85 contigs (N50 ϭ 30,161 bp and 176,814 bp) with 147-fold and 216-fold coverage of the genome were obtained for strain Bd1380 and strain Bd1980, respectively. The contigs for each strain were subjected to homology searches against the NCBI Database Nucleotide Collection using the BLASTN program (12) . Contigs with an insertion sequence at the end(s) and antimicrobial and mercury resistance genes were the first choices for the presumptive assemblage of the MDR genomic island. Gaps among the contigs were filled using PCR and Sanger sequencing methods. The complete sequence of the genomic island was verified by PCR mapping, and the whole sequence was subjected to BLAST analysis of the NCBI Database Nucleotide Collection for homology.
Our results revealed that S. Typhi strain Bd1980 contained an insertion of a 25,268-bp genomic island, designated Salmonella genomic island 11 (SGI11), in yidA, which encodes a sugar phosphate phosphatase, at bp 3815480 of the S. Typhi strain CT18 genome (GenBank accession number NC_003198), and that strain Bd1380 had 2 SGI11 insertions, one at bp 3815480 and the other in nlpC, which encodes a lipoprotein, at bp 1690327 of the S. Typhi strain CT18 genome. The 2 SGIs in strain Bd1380 had identical sequences. SGI11 was a composite transposon; it had a Tn21 backbone with an imperfect left inverted repeat and was flanked by two IS1 elements (Fig. 1) . This genomic island was flanked by perfect 9-bp direct repeats in the insertion site and comprised 27 open reading frames (ORFs), including genes involved in antimicrobial resistance (bla TEM-1 , catA1, strA, strB, sul1, sul2, and dfrA7) and mercury resistance (merD, merA, merC, merP, merT, and merR) and genes for the IS1, IS26, and Tn21 transposases, a Tn21 resolvase, a Tn21 modulator protein, a phase integrase, a truncated TniA transposase, and 3 putative proteins (Fig. 1) . Spanning the sequence from the intI1 gene to the first insertion site of IS26 (bp 6504 to 9740) was an In22 class 1 integron. All of the resistance genes, except catA1, resided in the Tn21 backbone. SGI11 had the best sequence homology to pAKU_1, an IncHI1 plasmid first identified in S. Paratyphi A (13). SGI11 consisted of 5 DNA seg-ments of pAKU_1 with 100% sequence identity in the same direction or in an inverted form (Fig. 1) . The greatest difference among the encoding ORFs was that the Tn21 resolvase gene was intact in SGI11 but interrupted by an IS26 in pAKU_1.
To investigate the distribution of SGI11 in the MDR S. Typhi isolates from Bangladesh, the remaining 24 MDR S. Typhi isolates were examined using PCR with the primers listed in Table 1 . The results indicated that the 11 isolates with pattern A2 and 6 isolates with pattern A6 contained one SGI11 insertion at bp 3815480 and that only one (strain Bd1380) with pattern A11 had two SGI11 insertions. SGI11-carrying S. Typhi strains were either susceptible or resistant to nalidixic acid and ciprofloxacin, suggesting that the integration of SGI11 in the chromosomes should occur before the development of resistance to nalidixic acid and ciprofloxacin in the strains.
Genomic islands are relatively large DNA segments, acquired via horizontal gene transfer, carrying a suite of genes to confer unique functions such as antibiotic resistance, fitness, new metabolic pathways, pathogenicity, and symbiosis that are beneficial to survival of bacteria in the environment (14) . Salmonella genomic islands SGI1 to SGI10 have been designated with respect to the DNA segments associated with antibiotic resistance (15, 16) or other functions (17) . Therefore, the genomic island identified in this study was designated SGI11. In the past decades, several chromosome-mediated multidrug resistances have been identified in S. enterica (15, (18) (19) (20) (21) . Salmonella strains harboring an MDR genomic island may be more virulent and have a tendency to rapidly disseminate (16, (22) (23) (24) . SGI1 carries genes conferring resistance to ACSSuT and hyperinvasion capability for the SGI1-bearing Salmonella strains, S. Typhimurium DT104 in particular, which have been the most prevalent MDR Salmonella strains since the 1990s (25, 26) . Recently, an SGI conferring resistance to ASSuT was identified among strains of S. Typhimurium and its monophasic variant (20) . This ASSuT-resistant clone soon became widespread in many European and Asia countries (27, 28) . SGI11 may be the first MDR genomic island identified in S. Typhi. SGI11-carrying S. Typhi strains may have the advantage in the face of antimicrobial exposure, and whether the strains are more capable of spreading needs further investigation. Notably, 11 of the 18 MDR S. Typhi isolates from Bangladesh analyzed in this study have developed resistance to high-level fluoroquinolone by alterations in gyrase A (S83F and D87G) and enhanced efflux pumps (9) . High-level fluoroquinolone resistance on salmonellae may have a prohibitive fitness cost (29) ; however, fluoroquinolone-resistant S. Typhi strains may have a fitness benefit even in the absence of antimicrobial pressure (30) . Thus, intensive surveillance is necessary to monitor the dissemination of the S. Typhi strains that bear chromosome-mediated resistance to multiple first-line antimicrobials and fluoroquinolone for the treatment of typhoid fever.
Nucleotide sequence accession number. The nucleotide sequence for SGI11 has been deposited in GenBank under accession number KM023773. 
